Embryologist Gemma Arroyo, coordinator of the Embryology Group of ESHRE and one of the directors of the IVF laboratories at Dexeus Mujer, was part of the working group that developed this guideline aimed at both patients and professionals.
Recently, two of our gynaecologists have presented their doctoral theses at Dexeus Mujer. They are Dr Pascual García Alfaro, Head of the Menopause Unit at Dexeus Mujer, and Dr Gabriela Quintero Polly, Gynaecologist and Obstetrician.
From 25th to 27th April, an international congress on reproductive medicine was held in Barcelona. The event was organised by the Dexeus Mujer Foundation, chaired by Dr Pedro Barri, under the scientific direction of Dr Nikolaos Polyzos, Head of the Reproductive Medicine Unit at Dexeus Mujer.
The European Society of Human Reproduction and Embryology has awarded Dexeus Mujer with the certificate of good clinical and laboratory practices. This accreditation is a guarantee that all processes related to these services meet the highest standards of safety and quality and attests to the quality of the working system of our centre.
Dexeus Mujer has participated in the 34th National Congress of the Spanish Fertility Society and the 9th Congress of Reproductive Nursing, which took place from 23 to 25 May in A Coruña.
A group of researchers at Dexeus Mujer, led by Dr. Mònica Parriego, has conducted a retrospective study to analyze whether partial compaction during morula formation in blastocysts can influence the developmental capacity and implantation potential…
The Sociedad Española de Fertilidad (SEF) (Spanish Fertility Society) has presented before the Senate a document agreed with seven other medical associations and representative agents in the field of fertility and reproductive health. Its aim is to open a social debate and promote political measures that contribute to tackling the alarming drop in the birth rate in Spain.
A team from the Reproductive Medicine Service of Dexeus Women, led by Dr Piotr Sokol and Dr Elisabet Clua, has carried out a retrospective study with the aim of developing and validating a clinical prediction model to improve reproductive outcomes…
Dr Pascual García Alfaro, head of the Dexeus Women’s Menopause Unit, has led a cross-sectional study that analyses whether there is an association between endogenous hormone levels and bone mineral density in postmenopausal women.
A group of researchers led by Dr Mª Ángeles Rodríguez, expert in Prenatal Diagnosis at Dexeus Mujer, has conducted an observational study to determine the prevalence of anomalies of the corpus callosum (AbnCC) in a large population sample and to assess whether a systematic screening protocol for AbnCC should be established for…
At the XII ASEBIR Congress held in Palma last November, the candidacy of BARCELONA, led by Dr Montserrat Boada of Dexeus Mujer, was proclaimed as its candidate for the next ASEBIR Congress, a scientific society that brings together most…
From the 13th to the 16th of December 2023, the second edition of the Catalan Week of Simulation was held. This event, emblematic in its focus on clinical safety, is distinguished by the use of simulation as a fundamental tool for medical training and preparation.
Aromatase inhibitors (AI) have proven to be effective in women with hormone receptor-positive breast cancer (BC). However, the frequent appearance of stiffness and arthralgias following treatment with AIs results in a worsening of their quality of life and leads to consultations…
The Clínica Sant Josep (CSJ), managed by the Althaia Foundation, and the Dexeus Mujer group have signed an agreement to implement a new healthcare model at this hospital located in central Catalonia, which offers highly specialised medical care…
A multidisciplinary group of researchers at Dexeus Mujer have carried out an extensive study to evaluate the impact of adenomyosis in women undergoing IVF treatment. In total, a sample of 3503 patients undergoing their first…
Sentinel lymph node (SLN) biopsy has recently been accepted to assess lymph node status in early-stage endometrial cancer, which is key to tailoring adjuvant treatments. However, it is unknown to what extent…
DEXEUS CAMPUS
Gran Vía de Carles III 71-75
08028 Barcelona
campus@dexeus.com
(+34) 93 227 47 09
® Copyright 2021-2025 Dexeus Mujer Foundation – Gran Via Carles III 71-75. 08028 Barcelona. Spain
